Volume 57, Issue 2, Pages (October 2000)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 72, Issue 7, Pages (October 2007)
Volume 68, Issue 4, Pages (October 2005)
Volume 65, Issue 1, Pages (January 2004)
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 6, Pages (December 2003)
Osteopontin expression in acute renal allograft rejection
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Osteopontin expression in human crescentic glomerulonephritis
Volume 68, Issue 6, Pages (December 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 4, Pages (October 2000)
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Volume 62, Issue 1, Pages (July 2002)
Volume 74, Issue 1, Pages (July 2008)
Volume 76, Issue 5, Pages (September 2009)
Volume 53, Issue 5, Pages (May 1998)
Volume 65, Issue 1, Pages (January 2004)
Volume 60, Issue 2, Pages (August 2001)
Volume 54, Issue 6, Pages (January 1998)
Volume 70, Issue 7, Pages (October 2006)
Volume 66, Issue 6, Pages (December 2004)
Infantile nephropathic cystinosis
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 6, Pages (December 2000)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Volume 63, Issue 1, Pages (January 2003)
Volume 54, Issue 3, Pages (September 1998)
Volume 63, Issue 4, Pages (April 2003)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 4, Pages (April 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 55, Issue 4, Pages (April 1999)
Volume 68, Issue 4, Pages (October 2005)
Volume 63, Issue 5, Pages (May 2003)
Volume 75, Issue 12, Pages (June 2009)
Volume 64, Pages S39-S45 (October 2003)
Volume 68, Issue 6, Pages (December 2005)
Volume 57, Issue 1, Pages (January 2000)
Volume 80, Issue 2, Pages (July 2011)
Volume 60, Issue 1, Pages (July 2001)
Volume 55, Issue 2, Pages (February 1999)
Volume 63, Issue 4, Pages (April 2003)
Local macrophage proliferation in human glomerulonephritis
Volume 61, Issue 6, Pages (June 2002)
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney  Yee-Yung Ng, Chun-Cheng Hou, Wansheng.
Volume 59, Issue 3, Pages (March 2001)
Volume 65, Issue 2, Pages (February 2004)
Expression of connective tissue growth factor in human renal fibrosis
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Crystals in podocytes: an unusual manifestation of systemic disease
Volume 62, Issue 2, Pages (August 2002)
Volume 72, Issue 7, Pages (October 2007)
Volume 57, Issue 2, Pages (October 2000)
Volume 59, Issue 5, Pages (May 2001)
Volume 67, Issue 3, Pages (March 2005)
Volume 55, Issue 6, Pages (June 1999)
Volume 56, Pages S47-S50 (July 1999)
Volume 69, Issue 11, Pages (June 2006)
Volume 58, Issue 4, Pages (October 2000)
Volume 59, Issue 5, Pages (May 2001)
Volume 121, Issue 3, Pages (September 2001)
Volume 69, Issue 10, Pages (May 2006)
Volume 63, Issue 1, Pages (January 2003)
Volume 73, Issue 5, Pages (March 2008)
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 56, Issue 3, Pages (September 1999)
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 57, Issue 2, Pages 499-509 (October 2000) Expression of macrophage migration inhibitory factor in human glomerulonephritis  Hui Y. Lan, M.D., Ph.D., Niansheng Yang, David J. Nikolic-Paterson, Xue Q. Yu, Wei Mu, Nicole M. Isbel, Christine N. Metz, Richard Bucala, Robert C. Atkins  Kidney International  Volume 57, Issue 2, Pages 499-509 (October 2000) DOI: 10.1046/j.1523-1755.2000.00869.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 In situ hybridization detecting macrophage migration inhibitory factor (MIF) mRNA expression in sections of normal and diseased human kidney. (A) Constitutive MIF mRNA expression by some glomerular and parietal epithelial cells and by tubular epithelial cells in a normal human kidney. (B) Membranous glomerulonephritis (GN) showing a mild to moderate up-regulation of glomerular MIF mRNA expression, largely by podocytes, but tubular MIF mRNA is unchanged compared to that seen in normal human kidney. (C) Mesangiocapillary proliferative GN (MCPGN), showing marked up-regulation of MIF mRNA by both glomerular and tubular epithelial cells. The increased MIF mRNA expression is most prominent within severe glomerular and tubulointerstitial lesions. (D) Lupus nephritis showing strong MIF mRNA expression in focal glomerular and tubulointerstitial lesions. Note that many of the infiltrating mononuclear cells within interstitial lesions express MIF mRNA. (E) IgAN showing distinct MIF mRNA expression by glomerular mesangial cells in addition to expression by glomerular epithelial cells. (F) Crescentic GN showing strong MIF mRNA expression within both the glomerulus and tubulointerstitium, contributing to crescent formation (*) and severe tubulointerstitial lesions. In addition, expression of MIF mRNA by vascular endothelial cells (arrowheads) was clearly identified in severe forms of GN (C, D, and F). Original magnification: ×100 (C), ×250 (A, B, D, and F), ×400 (E). Kidney International 2000 57, 499-509DOI: (10.1046/j.1523-1755.2000.00869.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Double immunohistochemistry staining of MIF protein (blue) and infiltrating macrophages and T cells (brown) in normal and diseased human kidney. (A) Constitutive expression of MIF protein by some glomerular and parietal epithelial cells and by most tubular epithelial cells in normal human kidney. (B) MCPGN showing a marked increase in MIF protein staining by glomerular endothelial cells (arrowheads) in association with a prominent infiltrate of KP1+ macrophages (brown). (C) Focal glomerulosclerosis (FGS) showing up-regulation of glomerular MIF expression with focal accumulation of KP1+ macrophages (brown). (D) Crescentic GN showing a dramatic increase in glomerular MIF immunostaining together with prominent infiltration of KP1+ macrophages (brown), resulting in severe glomerular damage and crescent formation (*). (E) Crescentic GN showing marked up-regulation of MIF expression by tubular epithelial cells in association with prominent accumulation of KP1+ macrophages (brown), leading to multinucleated giant cells (arrows) and granulomatous lesion formation. (F) Crescentic GN showing marked up-regulation of glomerular and tubular MIF expression in association with prominent infiltration of UCHL1+ T cells (brown) and the development of severe tubulitis (*). Note that many of the macrophages (B–E) and T cells (F) labeled in brown were double stained for MIF (blue). Sections were counterstained with periodic acid-Schiff minus hematoxylin. (Original magnification: ×100 A, F, and ×250 B–E). Kidney International 2000 57, 499-509DOI: (10.1046/j.1523-1755.2000.00869.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Quantitation of renal MIF mRNA and protein expression in normal and diseased human kidney. Staining of tissue sections for MIF mRNA and MIF protein was quantitated in the glomerulus (A and B) and in tubules (C and D) as described in the Methods section. Data are expressed as the mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 compared with normal kidney. Kidney International 2000 57, 499-509DOI: (10.1046/j.1523-1755.2000.00869.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Quantitation of MIF expression by infiltrating mononuclear cells in normal and diseased human kidney. Staining of tissue sections for KP1+ macrophages (□), UCHL1+ T cells (□), and cells double stained for MIF (KP1+MIF+ and UCHL1+MIF+, ▪) were quantitated in the glomerulus (A and C) and tubulointerstitium (B and D). Data are expressed as the mean ± SEM. The parentheses are the average percentage of glomerular and interstitial macrophages or T cells expressing MIF. *P < 0.05; **P < 0.01; ***P < 0.001 compared with normal kidney. Kidney International 2000 57, 499-509DOI: (10.1046/j.1523-1755.2000.00869.x) Copyright © 2000 International Society of Nephrology Terms and Conditions